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ABSTRACT
Astroglial cells, due to their passive electrical properties,
were long considered subservient to neurons and to merely
provide the framework and metabolic support of the brain.
Although astrocytes do play such structural and house-
keeping roles in the brain, these glial cells also contribute
to the brain’s computational power and behavioural output.
These more active functions are endowed by the Ca
2+-based
excitability displayed by astrocytes. An increase in cytosolic
Ca
2+ levels in astrocytes can lead to the release of signalling
molecules,a process termedgliotransmission, viatheprocess
of regulated exocytosis. Dynamic components of astrocytic
exocytosis include the vesicular-plasma membrane se-
cretory machinery, as well as the vesicular traffic, which is
governed not only by general cytoskeletal elements but
also by astrocyte-specific IFs (intermediate filaments).
Gliotransmitters released into the ECS (extracellular space)
can exert their actions on neighbouring neurons, to
modulate synaptic transmission and plasticity, and to affect
behaviour by modulating the sleep homoeostat. Besides
these novel physiological roles, astrocytic Ca
2+ dynamics,
Ca
2+-dependent gliotransmission and astrocyte–neuron
signalling have been also implicated in brain disorders, such
as epilepsy. The aim of this review is to highlight the newer
findings concerning Ca
2+ signalling in astrocytes and
exocytotic gliotransmission. For this we report on Ca
2+
sources and sinks that are necessary and sufficient for
regulating the exocytotic release of gliotransmitters and
discuss secretory machinery, secretory vesicles and vesicle
mobility regulation. Finally, we consider the exocytotic
gliotransmission in the modulation of synaptic transmission
and plasticity, as well as the astrocytic contribution to sleep
behaviour and epilepsy.
Key words: astrocyte, exocytosis, epilepsy, sleep, synaptic
transmission, traffic.
INTRODUCTION
The first description of neuroglia was made by Rudolf
Virchow as a ’substance… which lies between the proper
nervous parts, holds them together and gives the whole its
form in a greater or lesser degree’ (Virchow, 1858). The
1Correspondence should be addressed to either of these authors (email robert.zorec@mf.uni-lj.si or vlad@uab.edu or robert.zorec@mf.uni-lj.si).
Abbreviations: ADA, adenosine deaminase; ADK, adenosine kinase; ANP, atrial natriuretic peptide; 2-APB, diphenylboric acid 2-aminoethyl ester; [Ca
2+]i, cytosolic/
intracellular Ca
2+ levels; Cm, membrane capacitance; dnSNARE, dominant negative SNARE; ECS, extracellular space; EGFP, enhanced GFP; Emd, emerald green; ENT,
equilibrative nucleoside transporter; ER, endoplasmic reticulum; GABA, c-aminobutyric acid; GAT-1, GABA transporter-1; GFAP, glial fibrillary acidic protein; GFP, green
fluorescent protein; GluR, glutamate receptor; HEK-293 cells, human embryonic kidney cells; IF, intermediate filament; InsP3R, inositol 1,4,5-trisphosphate receptor; LTP,
long-term potentiation; mGluR, metabotropic GluR; NCX, Na
+/Ca
2+ exchanger; NMDAR, N-methyl-D-aspartate receptor; Ru360, Ruthenium 360; RyR, ryanodine receptor;
SERCA, sarcoplasmic/endoplasmic reticulum Ca
2+-ATPase; SNARE, soluble N-ethylmaleimide-sensitive fusion protein-attachment protein receptor; SOCE, store-operated
Ca
2+ entry; Sb2, synaptobrevin 2; SNAP-23, 23 kDa synaptosome-associated protein; SWA, slow wave activity; TIRFM, total internal reflection microscopy; TRP, transient
receptor potential; TRPC1, TRP canonical 1; V-ATPase, vacuolar type of proton ATPase; VGCC, voltage-gated Ca
2+ channels; VGLUT, vesicular glutamate transporter.
E 2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://




asnneuro.org / Volume 4 (2) / art:e00080 103original concept of glia being just a goo soon after was
refined to rather receive cellular attributes, as glial cells were
stained using ’reazione nera’ and visualized by Camillo Golgi
(Golgi, 1873). A subset of these cells was termed astrocytes by
Michael von Lenhossek (Lenhossek, 1891). Interestingly, the
gold chloride stain, used by Santiago Ramo ´n y Cajal in 1913
to visualize astrocytes, targets IFs (intermediate filaments;
Kimelberg, 2004), which consist mainly of GFAP (glial
fibrillary acidic protein) that is today used as an astrocytic
marker, while its promoter became a prime tool in molecule
genetics approaches (e.g. Pascual et al., 2005; Casper et al.,
2007) to study the role of astrocytes in the operation of the
brain. It is at the beginning of the 20th century that glial
research was pushed aside to a great extent by the victory of
the neuronal doctrine with neurons being the sole deter-
minant of the brain signalling. Of course, the fact that glial
cells lack classical electrical excitability was a contributing
factor. Following somewhat less than three quarters of a
century of neglect, there has begun a period of about the
past three decades during which extraordinary evidence has
mounted to present astrocytes as an integral component of
the brain operation. Owing to the development of fluorescent
Ca
2+ indicators, with non-disruptive intracellular loading, for
optical measurements of cellular free Ca
2+ (Tsien, 1980, 1981;
Grynkiewicz et al., 1985; Minta et al., 1989), in 1990, Cornell-
Bell et al. (1990) made a seminal observation that activation
of GluRs (glutamate receptors) in astrocytes raised their
cytosolic Ca
2+ levels. This finding was expanded to the
observation that astrocytes with their Ca
2+ responsiveness
have the ability to ’sense’ glutamatergic synaptic transmission
(Dani et al., 1992). This was followed by the discovery that
astrocytic Ca
2+ dynamics can yield astrocyte–neuron signal-
ling, with two initial studies immediately pointing to the
complexity of this intercellular communication by describing
two divergent underlying mechanisms: direct, perhaps using
gap junctions (Nedergaard, 1994); and indirect utilizing
glutamate released from astrocytes via Ca
2+-dependent
exocytosis (Parpura et al., 1994). The later path has led to
the discovery of gliotransmission-based modulation of
synaptic transmission (Araque et al., 1998a) and formulation
of the concept that three, pre- and post-synaptic neuronal
along with glial elements constitute a synapse (Kettenmann
et al., 1996), whose structural–functional partnership was
termed the tripartite synapse (Araque et al., 1999). An
additional level of complexity in the role of gliotransmission
was then the finding that the Ca
2+-dependent release of
vasoactive agents from astrocyte endfeet is at the basis
of neurovascular coupling (Zonta et al., 2003) and that
vesicles carrying gliotransmitters are subject to regulation
(Stenovec et al., 2007). This represents the current view of
synaptic physiology where astrocytes are actively involved in
the brain’s computational power. The aim of this review is to
highlight up-to-date newer findings with respect to Ca
2+
signalling in astrocytes and gliotransmission. We start with
the description of Ca
2+ sources and sinks that provide the
astrocytic intracellular Ca
2+ dynamics necessary and
sufficient for regulation of exocytotic release of gliotrans-
mitters. This is followed by a discussion on secretory
machinery which underlies this release mechanism, and a
description of secretory vesicles in astrocytes. It is the traffic
of these organelles throughout the astrocyte which ulti-
mately results in vesicular fusion to the plasma membrane
that liberates gliotransmitter(s) into the ECS (extracellular
space). It should be noted, however, that exocytosis also acts
as a delivery route for insertion and retrieval of, for instance,
receptors at the plasma membrane. Subsequently, we discuss
exocytotic gliotransmission in modulation of synaptic
transmission and plasticity, as well as astrocytic contribution
to sleep behaviour. Finally, we describe the consequences of
astrocytic Ca
2+ excitability in epilepsy, as an example of a





Calcium, rather than electrical, signalling is generally con-
sidered a substrate for glial excitability (Deitmer et al., 1998;
Verkhratsky et al., 1998; Agulhon et al., 2008). Calcium
intracellular signalling system is present in virtually all living
cells, being highly evolutionarily conserved (Case et al., 2007;
Verret et al., 2010). In eukaryotes, Ca
2+ signalling can couple
input to output, i.e. plasma membrane excitation to muscle
contraction, metabolic reactions, gene expression and
secretion. The excitation–secretion coupling that occurs
through regulated exocytosis provides the basis for chemical
transmission in the nervous system (reviewed in Parpura et al.,
2010). Astrocytes, the main homoeostatic cells in the CNS
(central nervous system), are no exception to this eukaryotic
evolutionary trait (reviewed in Parpura and Zorec, 2010). The
Ca
2+ signalling system involves several sets of molecules that
generate Ca
2+ concentration gradients, and provide pathways
for Ca
2+ diffusion between various cellular compartments,
which serve as sources and/or sinks for this ion. Cell
stimulation triggers concerted activation of these molecular
sets that produce a spatio-temporally organized transient
increase in the [Ca
2+]i (cytosolic/intracellular Ca
2+ levels),
which is sufficient and necessary for the engagement of
Ca
2+-sensitive effectors protein(s) of the secretory machinery.
Subsequently, this leads to vesicular fusion to the plasma
membrane liberating transmitters into the ECS, a process
that has been referred to as gliotransmission when occurring
in astrocytes. Below we summarize the role of several
compartments, the ER (endoplasmic reticulum), ECS and
mitochondria, for gliotransmission, in particular for Ca
2+-
dependent release of glutamate from astrocytes. The
portrayal of this subject is largely driven by results obtained
in vitro, although the final corroboration awaits further
experimentation using more intact preparations.
The ER represents a dynamic network of tubules and
cisternae distributed throughout the cell body, forming the
nuclear envelope and extending towards most distal
processes (Baumann and Walz, 2001; Verkhratsky, 2005).
R. Zorec and others
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2+ store that
generates and shapes cytosolic Ca
2+ signals. The ER has its
own Ca
2+ homoeostatic machinery represented by: (i) Ca
2+
pumps of SERCA (sarcoplasmic/endoplasmic reticulum Ca
2+-
ATPase) type that transport Ca
2+ into the ER lumen against
the concentration gradient; (ii) opposing leakage pathway
from the ER (Camello et al., 2002; Beck et al., 2004); and (iii)
Ca
2+ release channels. The latter are archetypal ligand-gated
channels, InsP3Rs (inositol 1,4,5-trisphosphate receptors) and
RYRs (ryanodine/caffeine receptors), activated by the second
messengers InsP3 and Ca
2+ ions respectively (Bezprozvanny,
2005; Galione and Ruas, 2005; Hamilton, 2005), which when
open allow Ca
2+ release down its concentration gradient
resulting in transient cytosolic Ca
2+ signals. The host of
metabotropic receptors expressed at the astrocytic plasma
membrane activate the phospholipase C/InsP3 signalling
cascade that results in the opening of InsP3Rs (Berridge,
1993; Kostyuk and Verkhratsky, 1994; Petersen et al., 1994),
which has been demonstrated in all types of glial cells in vitro
and in situ (see e.g. McCarthy and Salm, 1991; Kastritsis et al.,
1992; Finkbeiner 1993; Kirischuk et al., 1995, 1996; Peakman
and Hill, 1995; Verkhratsky et al., 1998; Agulhon et al., 2008).
Although the role for RyRs in shaping Ca
2+ release in
astrocytes in vivo remains debatable (Parpura et al., 2011),
there are some indices of their contribution to the physiology
of astrocytes, for instance, in ventrobasal thalamus (Parri and
Crunelli, 2003).
The contribution of the ER Ca
2+ release to gliotransmission
was deduced from experiments on cultured astrocytes,
which showed that inhibition of ER Ca
2+ accumulation by
thapsigargin, a specific SERCA blocker, largely reduced Ca
2+-
dependent glutamate release (Innocenti et al., 2000; Jeremic
et al., 2001; Hua et al., 2004) (Figure 1). Both InsP3Rs and
RyRs were conduits for Ca
2+ release from the ER to the
cytosol (Hua et al., 2004). This was evident by the reduction
of cytosolic Ca
2+ loads and glutamate release when astrocytes
were mechanically stimulated while being exposed to a
variety of pharmacological agents including: (i) 2-APB
(diphenylboric acid 2-aminoethyl ester), a cell-permeable
InsP3R antagonist (Maruyama et al., 1997), which can also
block the SOCE (store-operated Ca
2+ entry) (Kukkonen et al.,
2001; Bootman et al., 2002); (ii) ryanodine at concentration
which can block RyRs (Rousseau and Meissner, 1989; Henzi
and MacDermott, 1992; Golovina and Blaustein, 1997); (iii)
caffeine, which depletes the ER through persistent activation
of RyRs, but can also block InsP3Rs (Osipchuk et al., 1990;
Wakui et al., 1990; Ehrlich et al., 1994); and (iv) combination
of 2-APB with ryanodine or caffeine, without additive effect
when compared with treatments with one agent only
(Figure 1).
An additional source of Ca
2+ for gliotransmission comes
from the ECS, since exposure of astrocytes to Cd
2+, a broad
spectrum blocker of plasmalemmal Ca
2+ membrane channels,
reduced both mechanically induced cytosolic Ca
2+ loads and
glutamate release (Hua et al., 2004), this finding being in
agreement with the dual inhibitory action of 2-APB on the
InsP3R and the SOCE. Indeed, SOCE, activated following the
depletion of the ER Ca
2+ store, is generally present in all types
of glial cells (see e.g. Tuschick et al., 1997; Toescu et al., 1998;
Pivneva et al., 2008; Li et al., 2009). Some of the possible
SOCE molecular entities, the products of TRP (transient
receptor potential) genes, have been identified in astrocytes
and play a role in the regulation of astrocytic Ca
2+
homoeostasis and glutamate release (Pizzo et al., 2001;
Grimaldi et al., 2003; Golovina, 2005; Malarkey et al., 2008).
Hence, an acute immunological treatment using blocking
antibodies against the TRPC1 (TRP canonical 1) protein
channel pore significantly reduced mechanically induced
cytosolic Ca
2+ elevations and the consequential glutamate
release from cultured astrocytes (Malarkey et al., 2008)
(Figure 1).
In addition to SOCE, Ca
2+ entry from the ECS to the cytosol
can be mediated via plasma membrane voltage- and ligand-
gated Ca
2+ channels. Astrocytes in acute slices from
ventrobasal thalamus showed intrinsic cytosolic Ca
2+ oscilla-
tions which lead to glutamate release (Parri et al., 2001).
These oscillations were thapsigargin sensitive, thus requiring
Ca
2+ release from the ER. However, they also required Ca
2+
entry from the ECS since they were additionally sensitive to
nifedipine, a blocker of L-type VGCC (voltage-gated Ca
2+
channels) (Parri et al., 2001) (Figure 1). Conversely, the L-type
Ca
2+ channel positive modulator BayK8644 increased the
number of astrocytes exhibiting cytosolic Ca
2+ oscillations
Figure 1 Sources of Ca
2+ in Ca
2+-dependent glutamate release from
astrocytes
The accumulation of Ca
2+ in cytosol could be caused by the entry of Ca
2+
from the ECS through: (i) L-type VGCC [blocked by nifedipine (Nif)]; (ii) SOCE
via TRPC1 containing channels [blocked by antibodies against the channel
pore (Ab)]; and (iii) the plasma membrane NCX (the reverse mode blocked by
KB-R7943). The predominant source of Ca
2+ is available from the ER internal
store that possess InsP3R (blocked by 2-APB, which can also block SOCE) and
RyR [blocked by ryanodine (Ry)] channels acting as conduits for Ca
2+ delivery
to the cytosol. The ER store is (re)filled by SERCA [blocked by thapsigargin
(Thaps)]. Cytosolic Ca
2+ levels are modulated by mitochondria that can take-
up Ca
2+ via the Ca
2+ uniporter (blocked by Ru360) during the cytosolic Ca
2+
increase. As cytosolic Ca
2+ declines due to extruding mechanisms, Ca
2+ is
slowly released by mitochondria into cytosol via the mitochondrial NCX
(blocked by CGP37157) as well as by the formation of the mitochondrial
permeability transition pore [its opening blocked by cyclosporin A (CsA)]. The
increase in cytosolic Ca
2+ levels is sufficient and necessary to cause the fusion
of glutamatergic vesicles to the plasma membrane and exocytotic release of
glutamate. Drawing is not to scale.
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105(Parri and Crunelli, 2003). Although astrocytes in vitro and in
situ express several types of plasma membrane ligand-gated
Ca
2+ channels/ionotropic receptors (for detailed overview, see
Steinhauser and Gallo, 1996; Gallo and Ghiani, 2000;
Verkhratsky and Steinhauser, 2000; Lalo et al., 2011), their
role in exocytotic glutamate release from astrocytes remains
speculative at the moment.
An alternative pathway for trans-plasmalemmal Ca
2+
movements is controlled by NCXs (Na
+/Ca
2+ exchangers),
abundantly expressed in astrocytes (Goldman et al., 1994;
Takuma et al., 1994; Matsuda et al., 1996; Kirischuk et al.,
1997). When operating in the reverse mode, the NCX can
deliver Ca
2+ to the cytosol (Kirischuk et al., 1997; Rojas et al.,
2008). Hence, mild depolarization of astrocytes cultured from
adult rats caused NCXs to operate in the reverse mode to
generate cytosolic Ca
2+ increases leading to glutamate release
that were sensitive to 2-[2-[4-(4-nitrobenzyloxy)phenyl]
ethyl]isothiurea (KB-R7943) (Paluzzi et al., 2007) (Figure 1).
A similar role for NCX was observed when neonatal astrocytes
were mechanically stimulated (Reyes and Parpura, 2009).
Cytosolic Ca
2+ levels are also modulated by mitochondria
(Duchen et al., 2008). In mechanically stimulated astrocytes,
mitochondria rapidly sequester high cytosolic Ca
2+ via the
Ca
2+ uniporter. The inhibition of mitochondrial Ca
2+ uni-
porters with Ru360 (Ruthenium 360) increased mechanically
induced cytosolic Ca
2+ loads and potentiated the release of
glutamate (Reyes and Parpura, 2008) (Figure 1). Conversely,
as free cytosolic Ca
2+ is removed by pumps, such as the
SERCA and/or plasma membrane Ca
2+ ATPase, mitochondria
slowly release Ca
2+ into cytosol via the mitochondrial NCX, as
well as by the formation of the mitochondrial permeability
transition pore. The inhibition of mitochondrial Ca
2+ release,
either by blocking the mitochondrial NCX with 7-chloro-5-(2-
chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H)-one
(CGP37157) or by applying cyclosporin A which inhibits
opening of the mitochondrial permeability transition pore
(Basso et al., 2005), reduced both the cytosolic Ca
2+ loads and
consequential glutamate release (Reyes et al., 2012) (Figure 1).
Taken together multiple Ca
2+ delivery/retrieval pathways
are involved in regulating cytosolic Ca
2+ levels, which are
sufficient and necessary for triggering exocytotic release of
glutamate, and/or other gliotransmitters, from astrocytes
(reviewed in Parpura and Zorec, 2010). It should be noted,
however, that the sensitivity of secretory machinery to
cytosolic Ca
2+ can be modulated (Capogna et al., 1995; Wu
and Wu, 2001), which has been recently demonstrated in
cultured astrocytes (Reyes et al., 2011).
Regulated exocytosis and gliotransmission
The criteria for a chemical released from glia/astrocyte to be
classified as a ’gliotransmitter’ have been defined (Do et al.,
1997; Volterra and Meldolesi, 2005; Martin et al., 2007;
Parpura and Zorec, 2010) by a set of criteria: (i) synthesis
by and/or storage in glia; (ii) regulated release triggered
by physiological and/or pathological stimuli; (iii) activation of
rapid (milliseconds to seconds) responses in neighbouring
cells (paracrine), or to itself (autocrine); and (iv) a role in
(patho)physiological processes. Astrocytes are capable of
releasing a variety of gliotransmitters using three general
mechanisms/conduits: (i) plasma membrane channels
(Pasantes Morales and Schousboe, 1988; Cotrina et al.,
1998; Duan et al., 2003; Iglesias et al., 2009); (ii) plasma
membrane transporters (Szatkowski et al., 1990; Rosenberg
et al., 1994; Warr et al., 1999); and (iii) Ca
2+-dependent
exocytosis (Parpura et al., 1994; Calegari et al., 1999; Krzan
et al., 2003; Pangrsic et al., 2007); also reviewed in Parpura
and Zorec (2010). Owing to the ongoing debate on the role of
regulated exocytosis in gliotransmission (Smith, 2010), we
here report on the exocytotic release of three classes of
gliotransmitters: (i) amino acids, such as glutamate; (ii)
nucleotides, such as ATP; and (iii) peptides, such as ANP (atrial
natriuretic peptide).
Glutamate is synthesized within astrocytes via the
tricarboxylic acid cycle (Westergaard et al., 1996). Owing to
the expression of the enzyme pyruvate carboxylase, astro-
cytes can synthesize glutamate de novo (Hertz et al., 1999).
ATP is produced in cells by glycolysis and oxidative
phosphorylation. Extracellularly released ATP can directly
act on purinergic receptors, or indirectly, upon its hydrolysis
by membrane-bound ectonucleotidases to ADP and aden-
osine, can activate various plasma membrane receptors
(reviewed in Fields and Burnstock, 2006). Both glutamate
and ATP get loaded into vesicular lumen by vesicular
transporters (see below), unlike ANP which enters vesicles
via the synthetic secretory pathway, i.e., pro-ANP is made in
the ER, and after sorting into secretory vesicles it gets
processed to its final form, ANP, before being released
(Dannies, 1999).
Ca
2+-dependent exocytotic release of glutamate and
ATP depends on the presence of two sets of proteins: (i)
the SNARE (soluble N-ethylmaleimide-sensitive fusion
protein-attachment protein receptor) complex, responsible
for mediating vesicular and plasma membranes merger, con-
taining: Sb2 (synaptobrevin 2), or its homologue cellubrevin,
syntaxin 1, SNAP-23 (23 kDa synaptosome-associated
protein); and (ii) proteins responsible for sequestering
glutamate and ATP into vesicles: the V-ATPase (vacuolar type
of proton ATPase), which drives protons into the vesicular
lumen creating the proton concentration gradient necessary
for glutamate/ATP transport into vesicles via VGLUTs (vesi-
cular glutamate transporters) 1, 2 and 3 and VNUT (vesicular
nucleotide transporter) respectively (reviewed in Montana
et al., 2006; Parpura and Zorec, 2010) (Figure 2A).
Secretory vesicles are compulsory morphological elements
for exocytosis; a large variety of their sizes has been reported
in astrocytes (reviewed in Montana et al., 2006; Parpura et al.,
2010; Parpura and Zorec, 2010). In astrocytes, Sb2 can be
associated with vesicular structures ranging from 30 to 700
nm, the majority of which are electron-lucent (clear), while
,2% are dense core (Maienschein et al., 1999; Crippa et al.,
2006). Dense, and not so dense, core vesicles in cultured
R. Zorec and others
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secretory peptide secretogranin II (Calegari et al., 1999) and
ATP (Coco et al., 2003); subcellular fractions containing
secretogranin II were mainly distinct from fractions contain-
ing Sb2 (Calegari et al., 1999). Consistent with this finding
ANP fluorescent derivative [Emd (emerald green) appended]
puncta poorly co-localized with VGLUT1 signal (Kreft et al.,
2004), but they had ,35% co-localization with ATP (Potokar
et al., 2008). However, ,85% of Sb2 containing vesicles in
astrocytes co-localize with VGLUTs (Montana et al., 2004;
Bowser and Khakh, 2007); a subset of these Sb2 vesicles likely
contains other transmitters such as D-serine (Martineau et al.,
2008). Astrocytes in situ showed association of cellubrevin
and VGLUT 1 or 2 with small clear vesicles with a mean
diameter of ,30 nm (Bezzi et al., 2004) (Figure 2B). However,
photoconverted recycling dye FM1–43 labelled glutamatergic
vesicles with a measured diameter of 310 nm which was
comparable with their sizes in live cultured astrocytes (340
nm) obtained using differential interference contrast micro-
scopy (Chen et al., 2005). Visualization of vesicles expressing
the Sb2 fluorescent derivatives [GFP (green fluorescent
protein) or pHluorin appended] in astrocytes using TIRFM
(total internal reflection microscopy) gave an estimated
diameter of under ,100 nm (Bowser and Khakh, 2007) and
of ,312 nm (range 161–422 nm) (Malarkey and Parpura,
2011). Similarly, diameters of VGLUT2 or VGLUT1-pHluorin
expressing vesicles in astrocytes using TIRFM were estimated
to be ,40 nm (Cali et al., 2008; Marchaland et al., 2008).
Glutamatergic vesicles labelled by capturing an extracellular
antibody against VGLUT1 in a Ca
2+-dependent manner while
recycling with the plasma membrane are electron-lucent and
have diameters of ,50 nm (Stenovec et al., 2007). Similarly,
recycling peptidergic vesicles, capturing an extracellular
antibody against ANP, have diameters of ,50 nm (Potokar
et al., 2008). Vesicles found within gliosomes, subcellular
components of astrocytic processes isolated from brain by
fractionation (Nakamura et al., 1993), express Sb2 and
VGLUT1 and measure ,30 nm in diameter (Stigliani et al.,
2006). Taken together, it appears that there are three classes
of vesicles devoted to packaging of amino acids, nucleotides
and peptides with some overlap in co-packaging (see
summary in Table 1 of Parpura et al., 2010).
The process of exocytosis is characterized by quantal
release of transmitter, which has been demonstrated in
astrocytes using ’sniffer’ cells (Pasti et al., 2001; Pangrsic et al.,
2007) and fluorescent microscopy (Bezzi et al., 2004; Pangrsic
et al., 2007) for ATP and glutamate, while glutamatergic
vesicles containing a ’surrogate’ transmitter were also
interrogated using amperometry (Chen et al., 2005). Pasti
Figure 2 Release of gliotransmitters from astrocytes
(A)C a
2+-dependent glutamate release from astrocytes utilizes a vesicular
exocytotic pathway, which can be inhibited by: (i) a holoprotein of tetanus
toxin (TeTx) that cleaves vesicular SNAREs Sb2 and cellubrevin (Cb, red); (ii)
bafilomycin A1 (BA1) a specific inhibitor of V-ATPase (brown) which pumps
protons into the vesicular lumen; and (ii) Rose Bengal (RB), an allosteric site
modulator of VGLUTs (pink), transporters that utilize proton gradient to deliver
glutamate (Glu) into the vesicle. The plasma membrane SNAREs syntaxin 1
(green) and SNAP-23 (blue) form an acceptor complex for the vesicular SNARE
(Sb2/Cb red). Scissors and arrows indicate sites of actions for agents affecting
vesicular proteins. Drawing is not to scale. (B) Glutamatergic vesicles at the
putative tripartite synapse. Immunoelectron micrograph of VGLUT1 (small gold
particles) in astrocytic process (ast) is identified by the plasma membrane
glutamate transporters labelling (large gold particles). VGLUT1 positive vesicles
(insets,openarrowheads) in an astrocyteandin theadjacentneuronalterminal
(ter) have similarappearances;m,mitochondria.Scale bars, 100nm;and50nm
in insets. Reprinted by permission from Macmillan Publishers Ltd: Nature
Neuroscience, Paola Bezzi, Vidar Gundersen, Jose ´ Luis Galbete, Gerald Seifert,
Christian Steinha ¨user et al., 2004, Astrocytes contain a vesicular compartment
that is competent for regulated exocytosis of glutamate, Nature Neuroscience,
7(6), pp. 6132620, copyright (2004). (C) Exocytotic release of ATP from
astrocytes is quantal. Small transient inward currents (shaded in grey),
representing quantal release, can be recorded from ATP-sensing HEK-293 cells
cultured on astrocytes at rest (spontaneous release) and after these glial
cells were stimulated with glutamate (open bar); stimulation significantly
decreases the mean interval between detected currents. Reproduced from Tina
Pangrs ˇic ˇ, Maja Potokar, Matjaz ˇ Stenovec, Marko Kreft, Elsa Fabbretti, Andrea
Nistri, Evgeny Pryazhnikov, Leonard Khiroug, Rashid Giniatullin, Robert Zorec,
Exocytotic Release of ATP from Cultured Astrocytes, Journal of Biological
Chemistry, 282(39), pp 28749–28758. Copyright E 2007, by the American
Society for Biochemistry and Molecular Biology. (D–F) Preferred vesicular
fusion type in astrocytes is stimulus dependent. (D, E) Drawings depict
two vesicle fusion types described in astrocytes: (D) transient fusion, where a
vesicle remains intact and opens a transient fusion pore (arrow pointing down,
fusion; arrow pointing up, vesicleretrieval from theplasma membrane); and (E)
full fusion where a vesicle fully collapses into the plasma membrane upon
fusion (arrow). (F) Fusion events, categorized as either transient or full fusions
were plotted as a percentage of the total number of fusions that occurred,
either spontaneously or when cultured astrocytes were exposed to various
stimuli. Reproduced from Erik B. Malarkey and Vladimir Parpura, Temporal
characteristics of vesicular fusion in astrocytes: examination of synaptobrevin
2-laden vesicles at singlevesicle resolution, Journal of Physiology, John Wiley
and Sons E 2011 The Authors. Journal compilation E 2011 The Physiological
Society.
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107et al. (2001) transfected HEK-293 cells (human embryonic
kidney cells), which endogenously do not express GluR, with
NMDAR (N-methyl-D-aspartate receptor) subunits 1 and 2A.
These cells, termed NR cells, were co-cultured with astrocytes
and used as glutamate biosensors/reporters in whole-cell
patch clamp recordings. Selective glutamatergic stimulation
of astrocytes caused oscillatory [Ca
2+]i elevations in astro-
cytes as well as inward currents in adjacent NR cells
consistent with quantal release of glutamate from astrocytes.
Similarly, glutamate stimulation of astrocytes showed quantal
release of ATP as recorded by ATP biosensor (Pangrsic et al.,
2007), HEK-293 cells expressing a mutated P2X3 receptor
with reduced desensitization (Fabbretti et al., 2004)
(Figure 2C). Further evidence for vesicular exocytosis from
astrocytes came from the use of TIRFM (Bezzi et al., 2004;
Pangrsic et al., 2007). Pangrsic et al. (2007) incubated
astrocytes with quinacrine, a compound that fluorescently
labels ATP containing structures and shows punctate
appearance. The rapid loss of quinacrine puncta was evident
upon receptor stimulation using glutamate or ATP and the
Ca
2+ ionophore, ionomycin (Pryazhnikov and Khiroug, 2008).
Similar data were obtained for glutamatergic vesicles when
astrocytes in culture were transfected to express either VGLUT
1-EGFP (enhanced GFP) or VGLUT 2-EGFP chimaeric proteins
loaded with Acridine Orange and stimulated using a mGluR
(metabotropic GluR) agonist or ionomycin (Bezzi et al., 2004).
Additional evidence for quantal release from astrocytes was
obtained by amperometric measurements from cells pre-
incubated with the oxidizable transmitter dopamine, which
was stored in glutamatergic vesicles (Chen et al., 2005).
Exocytotic release of ANP, visualized as a disappearance of
fluorescent chimaeric protein ANP-Emd puncta (quanta), was
observed upon stimulation of astrocytes by ionomycin (Krzan
et al., 2003).
The delivery of secretory vesicles to the plasma membrane
exocytotic sites can be observed as an increase in the Cm
(membrane capacitance) due to a net addition of vesicular
membrane to the plasma membrane (Kreft et al., 2004).
Hence, stimulation to increase [Ca
2+]i caused an increase in
astrocyte Cm (Kreft et al., 2004; Zhang et al., 2004).
Interestingly, in astrocytes the maximal rate of Cm increase
(proportional to the rate of exocytosis) was at least two
orders of magnitude slower when compared with that in
neurons, measured by a similar method (Kreft et al., 2003).
In a subset of experiments where simultaneous measurements
of glutamate release and Cm were made, evoked glutamate
release from astrocytes was accompanied by an increase in Cm
in all cells (Zhang et al., 2004).
Using mainly neurons and chromaffin cells as models, two
types of vesicle fusion have been described: (i) full fusion,
where the vesicle collapses into the plasma membrane upon
fusion (Figure 2D), and (ii) transient fusion, where vesicles
remain attached to the plasma membrane and transiently
open the fusion pore (Figure 2E). Both modes of exocytosis
occur in astrocytes (Bezzi et al., 2004; Chen et al., 2005;
Bowser and Khakh, 2007; Cali et al., 2008; Marchaland et al.,
2008; Malarkey and Parpura, 2011). Spontaneously occurring
events had a similar ratio of transient to full fusions; the
preference for one fusion type over the other was stimulus-
dependent (Bowser and Khakh, 2007; Malarkey and Parpura,
2011) (Figure 2E). The consequence of transient versus full
fusion on release of gliotransmitters critically depends on the
measurements of the fusion pore. Such measurements would
allow us to assess the amount and/or type of gliotransmitter
(i.e., amino acid versus peptide) that could be released during
transient fusion events (Vardjan et al., 2007, 2009). In turn,
such differential release properties of the two forms of
vesicular release could have profound differential effects on
astrocytic modulation of synaptic transmission and plasticity
at the tripartite synapse (Araque et al., 1999).
Taken together, astrocytes possess functional secretory
machinery for release of various gliotransmitters, which in
turn can act upon neuronal receptors. The consequences of
such gliotransmitter-mediated astrocyte–neuron signalling
are further explored in upcoming sections below.
Mobility of secretory vesicles in astrocytes
Ca
2+-dependent exocytosis not only permits the exit of
vesicle lumen cargo, such as gliotransmitters into the ECS, but
also modifies important signalling membrane molecules,
including transporters, receptors, exchangers and ion pumps,
to be integrated by exocytosis into the plasma membrane
where they can take part in the signal transduction. Thus, the
understanding of vesicle traffic is crucial for uncovering
the role astrocytes play in signal integration in the brain.
Here, we will address vesicle traffic, vesicle delivery to and
removal from the site of exocytosis, a highly complex set of
processes at resting and stimulated conditions.
The traffic of vesicles likely evolved when eukaryotic cells
emerged 1000–2000 million years ago (Yoon et al., 2004). The
evolution of these cells was associated with a cell volume
increase by three to four orders of magnitude versus that of a
typical prokaryotic cell. The increased cell size dictated a new
organizational make-up. An important reason for this is that
signalling and communication within the relatively large
eukaryotic cell volume could no longer be supported mainly
by diffusion-based processes. While the transport of ions and
small molecules by diffusion in the sub-micrometre range is
physiologically appropriate, the diffusional mobility of larger
structures, such as vesicles, is predicted to be extremely slow,
proportional to the aqueous diffusion coefficient and the
inverse mass of the structure (Pusch and Neher, 1988).
The first studies in astrocytes revealed two types of
vesicular mobility, directional and non-directional (Potokar
et al., 2005, 2007). Directional mobility was observed as
vesicular tracks approximating straight-line appearance
(Figure 3A). In contrast to the non-directional type of vesicle
mobility, the directional mobility failed to exhibit a linear
relationship between the mean square displacement as a
function of time (Figure 3B), as is expected for diffusion-
based processes, but was better described by a quadratic
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mobility were observed in other cell types (Burke et al., 1997;
Tvarusko ´ et al., 1999; Duncan et al., 2003; Hill et al., 2004).
Vesicles exhibiting directional mobility are likely transported
along the cytoskeleton: their mobility may be modulated by
the dynamics of cytoskeletal elements, by different types of
molecular motor proteins associated with the cytoskeleton,
and by a variety of regulatory and signalling molecules
(Chang and Goldman, 2004).
In addition to microtubules and actin filaments as general
cytoskeletal elements, astrocytes also express the IFs, such as
GFAP, vimentin, nestin and synemin (Pekny et al., 1999; Pekny
and Pekna, 2004; Jing et al., 2007). It was shown that all three
classes of cytoskeletal elements play a role in directional
vesicle mobility in astrocytes (Potokar et al., 2007). Unlike
actin filaments and microtubules, IFs are devoid of en-
zymatic activity and are the least understood part of
the cytoskeleton (Eliasson et al., 1999; Chang and Goldman,
2004; Pekny and Pekna, 2004). While the first two types of
IFs, GFAP and vimentin, form the IF cytoskeleton in non-
reactive astrocytes in the adult brain (Pekny and Pekna,
2004), in reactive astrocytes, an increased expression of GFAP,
vimentin, nestin and synemin filaments was reported
(Eliasson et al., 1999; Jing et al., 2007). Since the
characteristics of single vesicle traffic was first described in
primary cultured astrocytes (Potokar et al., 2005), a question
often raised was how the overexpression of IFs in reactive
astrocytes, under pathological conditions, affects vesicle
Figure 3 Vesicular mobility in astrocytes
(A–C) Directional and non-directional vesicle mobility in resting astrocytes. (A) Examples of the mobility of vesicles, labelled by
expressing the fluorescent ANP (pro-ANP-Emd) in astrocytes. Vesicles labelled with numbers 2 and 3 show directional mobility with
elongated tracks (directional), whereas vesicles 1 and 4 exhibit non-directional mobility. Line on vesicle number 3 depicts the
maximal displacement the vesicle attained in the observation time of 15 s. (B) Directional vesicles and (C) non-directional vesicles
show the mean square displacement (MSD) of vesicle mobility as a function of time. Dashed line in (B) represents linear function
(typical for a diffusion-based process) fitted to the data using equation: MSD (mm
2)5(0.4702¡0.0099)6Time(s).




2). In (C) a linear function was fitted to the data following the equation:
[MSD (mm
2)5(0.0038¡0.0001)6Time(s)]. Reprinted from Biochem Biophys Res Commun, 329, Maja Potokar, Marko Kreft, Tina
Pangrs ˇic ˇ, Robert Zorec, Vesicle mobility studied in cultured astrocytes, 678–683, Copyright 2005, with permission from Elsevier.
(D, E) Post-fusion mobility of retrieved VGLUT1-positive vesicles in non-stimulated and stimulated astrocytes. Glutamatergic
vesicles were fluorescently labelled by exposing the astrocytes to the extracellular antibody recognizing the vesicle luminal domain
of the VGLUT1. Vesicle mobility was analysed by plotting vesicle maximal displacement (MD) as a function of the track length (TL).
Numbered lines represent fits to the data (equations in left panel in grey). Stimulated cells (E) were treated with Clostridium
spiroforme toxin (CST) to disintegrate actin filaments or left untreated (Con). Note that following the stimulation of cells by the
addition of ionomycin to raise cytosolic calcium levels, increased vesicular mobility is seen as the steeper slope of the line (number
2). If cells were pretreated by the toxin CST the slope of the line (number 3) remained unchanged in comparison with controls
(D, line number 1). (D, E) Reprinted from Experimental Cell Research, 313, Matjaz ˇS t e n o v e ce ta l . ,C a
2+-dependent mobility of
vesicles capturing anti-VGLUT1 antibodies, 3809–3818, Copyright (2007), with permission from Elsevier.
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109dynamics, in particular, how the traffic of distinct types of
vesicles is affected (Potokar et al., 2010, 2011).
In the initial studies, single vesicles were fluorescently
labelled by expressing pro-ANP-Emd in cultured astrocytes
(Potokar et al., 2005). To describe vesicle mobility, parameters
such as speed, step length, track length, maximal displace-
ment and mean square displacement, were estimated. Vesicles
containing recombinant peptide pro-ANP-Emd revealed
directional mobility (Figures 3A–3C) in 35% of vesicles
(Potokar et al., 2005), which is similar to the Sb2-EGFP
tagged vesicles, where 25% of vesicles were highly mobile
(Crippa et al., 2006). It is likely that the directional mobility
requires a cytoskeletal network, since disintegration of
microtubules, actin filaments and IFs significantly reduced
the population of vesicles exhibiting directional mobility
(Potokar et al., 2007). The role of IFs in vesicle traffic, where
they appear to be required for long-range directional vesicle
mobility, was unexpected, since these filaments were
considered previously to primarily maintain the cell shape
(Chang and Goldman, 2004).
There was one other unexpected finding. After the vesicle
membrane fuses with the plasma membrane transiently, the
vesicle is thought to be retrieved into the cytoplasm (Jahn
and Su ¨dhof, 1999; Taraska et al., 2003). The mobility of
retrieved vesicles was studied by labelling the vesicles with
extracellular antibodies, which were captured when the
vesicle lumen was temporarily exposed to the extracellular
medium during transient vesicle fusion (Stenovec et al., 2007;
Potokar et al., 2008); a similar approach was used to label
synaptic vesicles previously (Sara et al., 2005).
The mobility of retrieved vesicles differs from the
peptidergic vesicle traffic to the plasma membrane, in
the post-synthetic secretory pathway. First, the speed of
retrieving ANP and VGLUT1 vesicles is one order of mag-
nitude slower (,0.05 mm/s) than the speed of peptidergic
vesicles along the post-synthetic pathway towards the
plasma membrane. These velocities are similar to that of
ATP-containing vesicles (Pangrsic et al., 2007; Potokar et al.,
2008). Secondly, while it has been reported that an increase
in [Ca
2+]i does not cause a significant difference in the
mean velocity of pro-ANP-Emd labelled vesicles before and
after stimulation (Ng et al., 2002; Potokar et al., 2007), the
mobility of retrieved vesicles was altered following astro-
cyte stimulation by ionomycin to increase [Ca
2+]i.T h e
mobility of VGLUT1-positive vesicles was accelerated
(Figures 3D and 3E), while the mobility of ANP-positive
vesicles was attenuated (Stenovec et al., 2007; Potokar
et al., 2008). However, as with the vesicle traffic along the
post-synthetic pathway, the mobility of retrieved vesicles
was reported to be sensitive to the disintegration of
microtubules, actin filaments and IFs (Stenovec et al.,
2007; Potokar et al., 2008), consistent with results on the
impaired traffic of vesicles carrying the GPCR (G-protein-
coupled receptor) cannabiniod receptor 1 in astrocytes in
which the dynamics of actin filaments or microtubules was
perturbed (Osborne et al., 2009).
To test that the vesicle mobility recorded in cultured
astrocytes also occurs in vivo, vesicle dynamics was studied in
brain slices in which cell-to-cell contacts are preserved and
tissue architecture is closer to the one present in the brain
(Potokar et al., 2009). The mobility of specifically labelled
recycling glutamatergic and peptidergic vesicles (immuno-
positive for VGLUT1 or ANP respectively) was similar to that in
cultured astrocytes (Stenovec et al., 2007; Potokar et al., 2008).
To learn whether the accelerated/inhibited vesicle mobility
requires the IFs, wild-type and double IF (GFAP
2/2 and
vimentin
2/2) knock-out astrocytes were studied. The results
have shown that the stimulus-accelerated mobility of
VGLUT1-positive glutamatergic vesicles, and the stimulus-
inhibited mobility of ANP-positive peptidergic vesicles was
absent in astrocytes without IFs. Moreover, the stimulus-
mediated-inhibition of endosome/lysosome mobility was
absent in cells devoid of IFs (Potokar et al., 2010). Thus, IFs
play an important role in vesicle mobility regulation. One
can thus expect that in reactive astrocytes, where IFs are
overexpressed, this may differentially affect the stimulation-
dependent mobility of recycling vesicles and endosomes
(Potokar et al., 2011). More direct evidence that pathological
states in astrocytes may affect vesicle traffic was provided
recently, where the mobility of endosomes/lysosomes in
cultured astrocytes was increased upon the application of
amyotrophic lateral sclerosis IgG (Stenovec et al., 2011).
In summary, recent studies of single vesicle traffic in
astrocytes revealed complex properties of glutamatergic
and peptidergic vesicle mobility and their specific responses
to extracellular stimuli. It appears that all vesicle types in
astrocytes do not respond to altered physiological and
pathological conditions in the same pattern. This may
represent a new cellular paradigm of how astrocytes
contribute to the phenotype of brain function in physio-
logical and pathological conditions. One of the key questions
for the future is to learn about the molecular mechanisms
that mediate stimulus-dependent vesicle mobility regulation.
Moreover, we need further insights into the role of factors
that affect vesicle mobility and whether these manifest at a
more systemic level.
Astrocytes modulate synaptic transmission
The elucidation of the functional consequences of gliotrans-
mission on brain physiology has emerged as one of the most
appealing topics in contemporary neuroscience. Astrocytes
may release different neuroactive molecules, such as
glutamate, D-serine, ATP, adenosine, GABA (c-aminobutyric
acid), TNFa (tumour necrosis factor a), prostaglandins,
proteins and peptides that can potentially influence neuronal
activity and synaptic physiology (Volterra and Bezzi, 2002;
Perea et al., 2009). Glutamate, one of the first recognized
gliotransmitters originally identified in culture (Parpura et al.,
1994), has been shown to regulate synaptic transmission in
cultured hippocampal cells (Araque et al., 1998a, b) and
hippocampal slices. Glutamate released from astrocytes may
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synaptic transmission depending on the type of synapses,
the neuronal sites of action and the subtypes of receptors
activated. Astrocytic glutamate enhances the frequency of
spontaneous and evoked excitatory synaptic currents
through the activation of presynaptic group I mGluRs at
hippocampal CA3–CA1 synapses (Newman, 2003; Liu et al.,
2004b; Perea and Araque, 2007; Navarrete and Araque, 2010)
or presynaptic NMDARs at mossy fibres of the hippocampal
dentate gyrus (Jourdain et al., 2007). It can also affect inhibi-
tory transmission, inducing the potentiation (Kang et al.,
1998) or depression of inhibitory synaptic currents by acti-
vation of presynaptic kainate (Liu et al., 2004a) or group II/III
mGluRs (Martin et al., 2007) respectively. The fact that a
single gliotransmitter can exert multiple effects provides
a high degree of complexity (Figure 4) to the possible impact
of the astrocyte–neuron communication on network function.
Besides glutamate, other gliotransmitters such as ATP and
its metabolic product adenosine have also been shown to
modulate synaptic transmission. The astrocytic release of
ATP, which is converted into adenosine by extracellular
nucleotidases, is responsible for the presynaptic A1 receptor
activation that tonically depresses neurotransmission
(Serrano et al., 2006) and mediates heterosynaptic depres-
sion in hippocampal CA3–CA1 synapses (Zhang et al., 2003;
Panatier et al., 2006; Serrano et al., 2006). Adenosine itself
directly released from astrocytes under hypoxic conditions
has also been shown to down-regulate synaptic transmission
in those synapses through activation of presynaptic A1
receptors (Martin et al., 2007). Furthermore, a more recent
study has shown that basal synaptic transmission in C
A3–CA1 synapses is up-regulated by the release of ATP/
adenosine that tonically activates A2A receptors (Panatier
et al., 2011). Again, as in the case of glutamate, these studies
exemplify how a single gliotransmitter may have multiple
and contrasting effects on synaptic transmission and, hence,
in neural network function.
The fact that astrocytes may release different gliotrans-
mitters and that a single gliotransmitter may act on different
receptors and in different neuronal elements could provide
apparent contradictory results. However, the existence of
different regulatory effects should rather be regarded as
complementary mechanisms that provide a high degree of
complexity in the astrocytic control of the synaptic
physiology. Experimental studies are generally designed to
reveal the involvement of astrocytes in particular synaptic
phenomena. However, the consequences of the astrocytic
regulation of synaptic function can be much more complex in
an actual neural network that is dynamically active because
different neuromodulatory mechanisms can be simulta-
neously present. The influence of astrocytes, which are
capable of releasing various gliotransmitters on synaptic
transmission and neural network function, could be extre-
mely diverse depending on the type of gliotransmitter
released, the nature of the synapses involved, the type of
neuronal receptors targeted as well as their pre- or post-
synaptic localization. The temporal properties of these
regulatory mechanisms may also be important. For example,
sustained astrocytic purinergic signalling, which tonically
up- or down-regulates synaptic activity through activation of
A1 or A2A receptors (Pascual et al., 2005; Serrano et al., 2006;
Panatier et al., 2011) may co-exist with a phasic glutamate
signalling evoked by acute astrocytic calcium elevations that
transiently potentiate synaptic transmission by activating
presynaptic mGluRs (Fiacco and McCarthy, 2004; Perea and
Araque, 2007; Navarrete and Araque, 2010) or NMDARs
(Santello et al., 2011), which would provide higher degrees of
freedom to the neural network activity.
Taken together, the functional consequences of astrocyte
activity on synaptic function depend on the magnitude and
spatial and temporal properties of the astrocyte calcium
signal responsible for gliotransmitter release (i.e. which, when
and where a type of gliotransmitter is released), as well as on
the neuronal elements involved (i.e. what type of synapses,
what type of receptors are activated and where in the pre- or
post-synaptic membrane). At present we are gaining a better
understanding of astrocyte involvement in synaptic physi-
ology by revealing the possible regulatory mechanisms that
may contribute to the astrocyte neuromodulation, but a
detailed characterization of the physiological conditions, the
astrocytic cellular code and the specific intercellular
signalling that lead to the particular neuromodulation is
necessary to coherently understand the actual consequences
of synaptic transmission modulation by astrocyte activity on
neural network function.
The astrocytic release of the gliotransmitter D-serine has
also important consequences for the modulation of synaptic
Figure 4 Astrocytes modulate synaptic transmission
Astrocyte calcium signal triggered by synaptic activity stimulates the release
of different gliotransmitters, such as glutamate, ATP/adenosine or D-serine.
These gliotransmitters act on specific glutamate a-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid (AMPA), NMDAR and mGluR and adenosine
(A1 and A2A) receptor types localized at the pre- or post-synaptic neurons.
The consequently activated intracellular signalling pathways lead to
depression or potentiation of synaptic transmission.
Astrocytic excitability and transmission
E 2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
111transmission properties. D-serine has been shown to be an
endogenous ligand of the glycine-binding site of the
NMDARs that acts as a co-agonist for these receptors and
has important implications in glutamatergic transmission. In
the hypothalamic supraoptic nucleus, changes in the
astrocytic coverage of synapses under different physiological
conditions result in changes in the ambient levels of D-serine
released by astrocytes and its availability for NMDAR
activation, thus influencing NMDAR-mediated synaptic
responses (Panatier et al., 2006).
Long-term synaptic changes, considered to represent the
cellular mechanisms underlying learning and memory, can
also be influenced in multiple forms by different gliotrans-
mitters released from astrocytes. Some mechanisms are based
on a tonic mode of action of astrocytic gliotransmitters that
tonically and persistently regulate synaptic transmission
(Serrano et al., 2006; Stellwagen and Malenka, 2006;
Henneberger et al., 2010; Panatier et al., 2011). As a
consequence of the above described modulation of NMDAR
activity by astrocytic D-serine, astrocytes regulate the
amplitude and direction of the synaptic plasticity in the su-
praoptic nucleus (Panatier et al., 2006). Likewise, astrocytes in
the CA1 area of the hippocampus control NMDAR-mediated
synaptic plasticity through the release of D-serine
(Henneberger et al., 2010). ATP/adenosine released from
astrocytes has also been shown to govern the strength of
the basal hippocampal synaptic activity by tonic suppression
of neurotransmission, which results in an increase in the
dynamic range for LTP (long-term potentiation) (Pascual et al.,
2005). In addition, astrocytes also participate in the
generation of LTP in hippocampal CA3–CA1 synapses through
a phasic signalling process, in which the temporal coincidence
of the astrocyte calcium signal and the postsynaptic neuronal
activity induces LTP through the activation of presynaptic
group I mGluRs by calcium-dependent glutamate release
from astrocytes (Perea and Araque, 2007).
Although most of the studies on synaptic transmission
modulation by astrocytes have been performed on hippo-
campal slices because of their suitability as an experimental
model to study synaptic transmission, synaptic regulation by
astrocytes can be considered as a general phenomenon in the
nervous system, as indicated by its presence in other brain
areas, such as the retina, supraoptic nucleus and cerebellum,
as well as in the PNS (peripheral nervous system) (for reviews,
see Pascual et al., 2005; Jourdain et al., 2007; Perea et al.,
2009). However, to fully understand the role of astrocytes in
brain function, it should be considered that astrocytes are
largely interconnected cells through the expression of
connexins, the membrane protein constituents of gap
junction channels and hemichannels. Therefore, the existence
of astroglial networks adds further complexity to the
neuroglial networks underlying brain function (Giaume,
2010).
In conclusion, accumulating evidence obtained during
recent years has shown that astrocytes not only respond to
neuronal activity but also actively modulate synaptic
transmission and plasticity, demonstrating the existence
of reciprocal communication between neurons and astro-
cytes. This evidence has led to the establishment of the
concept for the tripartite synapse (Araque et al., 1999;
Perea et al., 2009), which represents a novel functional
view of synaptic physiology where astrocytes are relevant
elements actively involved in synaptic function and
neurophysiology.
Astrocytes modulate sleep homoeostasis through
their control of adenosine
A significant challenge in studying the role of the astrocyte in
brain function has been the development of strategies that
allow one to determine how these glial cells regulate synapses,
neural networks and ultimately behaviour. Towards these
goals, it was necessary to develop various lines of astrocyte
specifictransgenicmicethatallowtheevaluationoftheroleof
glial signalling pathways in the control of brain function
(Pascual et al., 2005; Fellin et al., 2009). One such line in the
dnSNARE (dominant negative SNARE) mouse expressing a
cytosolic domain of Sb2 in astrocytes in the adult brain is due
to conditional and selective transgenic targeting. Initial studies
in situ using hippocampal slices revealed that the expressionof
dnSNARE in astrocytes led to an increase in the magnitude
of excitatory synaptic transmission at the CA3–CA1 synapse
(Pascual et al., 2005). By performing pharmacological studies it
was determined that this enhancement of synaptic transmis-
sion resulted from a reduction in the activation of presynaptic
A1 receptors (Figure 5) (Pascual, 2005). It is well known that
there is a basal level of extracellular adenosine that tonically
exerts a presynaptic inhibition of synaptic transmission.
Figure 5 Pathways for synthesis, uptake and release of purines that may
contribute to sleep homoeostasis
Astrocytes release ATP through a SNARE-dependent mechanism. In the ECS,
ectonucleotidases, such as CD73, can convert ATP into adenosine, which can
be taken up by astrocytes via ENT. Intracellular adenosine can be converted
into AMP or inosine by the action of ADK and ADA respectively. Astrocyte-
mediated accumulation of extracellular adenosine leads to the activation of
neuronal adenosine (A1) receptors resulting in modulation of synaptic
transmission and sleep homoeostasis. Experimentally manipulated entities
that support this model are shown in red. See text for additional details.
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dnSNARE expression removed the source of adenosine, thereby
enhancing synaptic transmission (Pascual et al., 2005).
Independent work using entirely different strategies (Serrano
et al., 2006) provided significant evidence in support of the
notion that astrocytes can regulate extracellular adenosine.
There are many pathways that regulate extracellular
adenosine (Figure 5). One possible pathway is mediated
through the diffusion of adenosine down concentration
gradients that is facilitated by plasma membrane ENTs
(equilibrative nucleoside transporters). Pascual et al. (2005)
tested the importance of this pathway by pharmacologically
inhibiting the transporter and determining whether it led to
altered adenosine-dependent signalling. Following inhibition,
adenosine-mediated presynaptic inhibition was enhanced, a
result that is consistent with the transporter normally being
used to uptake adenosine from the extracellular to
intracellular milieu. Pascual et al. (2005) therefore sought
the identification of a different pathway of extracellular
adenosine accumulation. One potential pathway is mediated
by the release of ATP. Once released into the ECS ATP can be
hydrolysed to adenosine by extracellular nucleotidases.
Extracellular bioluminescence imaging studies demonstrated
that astrocytic dnSNARE expression caused a reduction in
extracellular ATP. Moreover, the addition of exogenous ATP
rescued the normal adenosine tone in slices obtained from
dnSNARE mice. Collectively, these results suggest that via a
SNARE sensitive mechanism, presumably exocytosis, astro-
cytes release ATP which is hydrolysed in the ECS to adenosine.
This adenosine modulates synaptic transmission and is cleared
via uptake through ENTs (Figure 5).
Having demonstrated that the astrocyte is critical for the
control of adenosine, one can turn attention to potential
behavioural phenotypes that result. It is well known that
adenosine can modulate sleep (Basheer et al., 2000, 2004). For
example, during wakefulness adenosine levels rise. Sleep
deprivation leads to sustained adenosine elevations and
infusion of adenosine promotes sleep. Additionally, adenosine
receptor antagonists, including caffeine, promote wakeful-
ness. The ability to selectively express dnSNARE only in
astrocytes and thereby regulate the glial source of adenosine
permitted investigations of whether astrocytes might modu-
late sleep systems.
There are two predominant modulators of sleep: the
circadian oscillator that controls the timing of sleep and
the sleep homoeostat that integrates the time awake
and promotes sleep drive. Adenosine is implicated in the
control of sleep homoeostasis. Using electroencephalography,
Halassa et al. (2009) asked whether the astrocyte contributes
to sleep homoeostasis. The drive to sleep can be assessed by
measuring the power of SWA (slow wave activity) during
non-rapid eye movement sleep. Following sleep deprivation,
for example, SWA is enhanced. Under baseline conditions the
power of SWA was reduced in dnSNARE mice and dnSNARE
expression attenuated the responses to sleep deprivation.
Following a period of sleep deprivation there is a compens-
atory increase in sleep time. Mice expressing dnSNARE in
their astrocytes do not exhibit this increase of sleep time.
Pharmacology performed in vivo demonstrated that inhibi-
tion of A1 receptors, the target of astrocyte-derived
adenosine, phenocopied the dnSNARE phenotype (Halassa
et al., 2009) (Figure 5).
This astrocyte adenosine mediated concept of the control
of sleep homoeostasis is supported by additional studies.
For example, mice with pan-cell knockout of the enzyme
ecto-59-nucleotidase, also known as CD73, necessary for
extracellular hydrolysis of AMP to adenosine (Mochizuki
et al., 2008), as well as mice with conditional neuron-specific
A1 receptor deletion both show similar sleep phenotypes to
dnSNARE mice (Bjorness et al., 2009) (Figure 5). Over-
expression of ADK (adenosine kinase), an intracellular enzyme
that is normally enriched in astrocytes and is responsible
for the intracellular phosphorylation of adenosine to AMP,
with concomitant conversion of ATP to ADP, leads to sleep
phenotypes (Palchykova et al., 2010) (Figure 5). Interestingly,
humans with specific mutations in ADA (adenosine deami-
nase), which leads to reduced intracellular metabolism of
adenosine to inosine, have an increased depth of sleep (Re ´tey
et al., 2005).
These results demonstrate the importance of adenosine
and the astrocytic control of this purine in the control of
sleep homoeostasis and point to the importance of these glial
cells in the control of brain circuits underlying behaviour.
Since many disorders of the brain have co-morbid sleep
disorders it will be intriguing to determine the contribution
of astrocytes to such disorders and whether targeting
astrocytes could act as potential therapeutic strategies.
Astrocyte calcium and network modulation –
epilepsy
Although we are beginning to understand how deep and wide
the impact of astrocyte-to-neuron signalling might be on
neuronal functions in physiological conditions (Halassa and
Haydon, 2010), an involvement of astrocytes in certain brain
disorders is also gradually emerging (Maragakis and
Rothstein, 2006; Seifert et al., 2006, 2010; Wetherington
et al., 2008; Blackburn et al., 2009). One of the brain disorders
in which astrocytes have been proposed to play a relevant
role is epilepsy, a family of multifactorial brain diseases
affecting at least 50 million people worldwide (Baulac and
Pitkanen, 2009). The clinical manifestation of epilepsy is the
seizure, a highly synchronous electrical discharge arising in a
population of neurons from a relatively small region (i.e. the
epileptogenic focus) that secondarily spreads across the brain
by a progressive recruitment of other neuronal populations
(Traub and Wong, 1982; Jefferys, 1990; Avoli et al., 2002;
Pinto et al., 2005; Trevelyan et al., 2006). Epilepsy can be
considered a disorder of excessive synchronization of
neurons, fundamentally linked to an imbalance between
excitatory and inhibitory activities that produces a hyper-
excitable neural network.
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113The hyperexcitable neuronal network that characterizes
the epileptic brain is generally believed to originate from
abnormalities intrinsic to neurons (McNamara et al., 2006),
but non-neuronal mechanisms may also contribute (Konnerth
et al., 1986; Dudek et al., 1998; Jefferys, 2003). A role
of astrocytes as modulators of epileptogenesis was initially
proposed over 20 years ago and for a long period it focused
on the ability of astrocytes to buffer extracellular K
+ or
neurotransmitters (released in excess during epileptic
discharges). Studies performed over the last decade, in both
animal models and human epilepsy strengthened the view
that a dysregulation of K
+ buffering in the astrocyte network
can predispose to neuronal hyperexcitability and contribute
to establish an epileptic condition (Bordey and Sontheimer,
1998; Hinterkeuser et al., 2000; Kivi et al., 2000; Schroder
et al., 2000; Wallraff et al., 2006).
A more direct role of astrocytes in the generation of
epileptiform activities was proposed only recently. The first
clue for such a role came from demonstration that through
the Ca
2+-dependent glutamate release, and possibly D-serine
(Mothet et al., 2005; Panatier et al., 2006), astrocytes can
directly excite groups of neighbouring neurons and favour
NMDAR-dependent synchronized activities (Fellin et al.,
2004). Following this observation, studies in brain slice
preparations and in vivo reported a significant increase in the
Ca
2+ oscillation frequency in astrocytes during epileptiform
activity (Tian et al., 2005; Fellin et al., 2006), and its reduction
in the presence of anticonvulsant drugs (Tian et al., 2005). The
Ca
2+-dependent glutamate release in astrocytes, and the con-
sequent activation of extracellular NMDARs in neurons, was
then found to contribute to cell loss in cortical and hi-
ppocampal regions during experimentally induced status
epilepticus (Ding et al., 2007). In support of a direct astrocyte
role in focal epilepsies, it was recently revealed that in the
presence of the proconvulsant 4-aminopyridine astrocytes
exhibited massive Ca
2+ elevations upon an episode of intense
neuronal activity (Losi et al., 2010) and by signalling back
to neurons they generated a recurrent excitatory loop with
neurons that had the potential to promote a focal seizure
(Gomez-Gonzalo et al., 2010). Altogether, these results
suggest that a hyperexcitable neuronal network may arise
in the brain as a product of a dysregulation of local neuron-
astrocyte reciprocal signalling and generate a focal site of
seizure initiation.
Although these observations represent significant advances
in our knowledge of the possible role of astrocytes in
epilepsy, many important issues need to be defined. For
example, the effect on epileptiform activities of other
gliotransmitters, such as ATP, D-serine and GABA, or of
inflammatory agents, such as cytokines and chemokines that
are potentially released by activated astrocytes, has been not
specifically addressed. Notably, not necessarily all these
factors have proconvulsant effects. The observations that
under physiological conditions adenosine derived from
astrocytic ATP leads to inhibition of transmitter release and
heterosynaptic depression by acting on presynaptic A1
receptors are, indeed, consistent with an anticonvulsant role
of astrocytes. Also noteworthy is that seizure induction in
experimental epilepsy was found to decrease adenosine
extracellular concentrations through an up-regulation of
astrocytic enzyme ADK that controls ambient adenosine
levels (Boison, 2005), while genetic reduction of ADK
was observed to prevent seizures (Li et al., 2008). The
overexpression of astrocytic ADK recently observed in
hippocampal and cortical specimens from patients with
temporal lobe epilepsy strengthens the hypothesis that a
dysregulation of this enzyme in astrocytes is a hallmark of the
chronic epileptic brain tissue (Aronica et al., 2011).
The potential impact on seizure activity of astrocytes can
be even more complex if we take into account that a
gliotransmitter, such as glutamate, may affect not only
excitatory but also inhibitory transmission (Kang et al., 1998;
Benedetti et al., 2011). It follows that the overall effect of
gliotransmission on the neuronal network excitability may
ultimately depend not only on the type of gliotransmitter
predominantly or selectively released but also on the distinct
functional connectivity between astrocytes and different types
of neurons from a specific brain region. As an excessive
neuronal synchrony can arise as a result of inhibitory
transmission impairment, it would be of great interest to
understand whether a distinct signalling pathway exists
between astrocytes and different GABAergic interneurons,
and how it eventually changes in the epileptic brain tissue.
Astrocytes may contribute to epileptogenesis also through a
number of different mechanisms. For example, a malfunction
of the astrocytic plasma membrane glutamate transporters
that critically control extracellular glutamate concentrations is
a common feature in temporal lobe epilepsy. A recent study
also revealed that the astrocytic plasma membrane GAT-1
(GABA transporter-1) likely has a central role in absence
epilepsy (Cope et al., 2009). This form of non-convulsive
epilepsy is characterized by synchronous spike-and-wave
discharges arising in thalamo-cortical networks. In various
well-established experimental models, the enhanced tonic
inhibition, whichin theventrobasal thalamus crucially controls
absence seizure generation, was regularly found to develop as
a consequence of GAT-1 malfunction (Cope et al., 2009).
As GAT-1 expressioninthe thalamusismainly, if not exclusively,
confined to astrocytes (De Biasi et al., 1998; Vitellaro-Zuccarello
et al., 2003), these cells may be potential targets for the
development of a new therapy in absence epilepsy.
A full clarification of the functional significance of the
multiple signals that astrocytes exchange with neurons
represents an intriguing challenge in the years to come.
With a better understanding of astrocyte roles in both brain
physiology and pathology, gliotransmission might be recog-
nized as a target for developing new anti-epileptic therapies.
It is also worth underlining that the changes occurring in
astrocyte signalling in the epileptic tissue may resemble the
dysregulation of molecules and pathways that occur in other
brain disorders. Indeed, astroglial GluRs and transporters,
water channels (aquaporins), inward rectifier K
+ channels and
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but also in motor-neuron disease, stroke, hepatic encephalo-
pathy, schizophrenia, Huntington’s disease and Alzheimer’s
disease (Blackburn et al., 2009; Maragakis and Rothstein,
2006; Seifert et al., 2006). All in all, these studies suggest that
astrocytes might hold the key to understand the pathogenesis
of these brain disorders.
To improve our understanding we need, however, the re-
sults obtained from in vitro models to be validated in the
intact brain. With the recent development of optogenetic
tools to stimulate astrocytes selectively (Airan et al., 2009;
Figueiredo et al., 2011; Gourine et al., 2010), and of new more
sensitive, genetically encoded Ca
2+ sensors, such as GCaMP3
(Shigetomi et al., 2011), we have now the opportunity to
study how astrocyte Ca
2+ signalling can affect network
activities in the living brain.
A full clarification of the functional significance of the
multiple signals that astrocytes exchange with neurons
represents an intriguing challenge in the years to come.
With a better understanding of the astrocyte roles in both
brain physiology and pathology, gliotransmission might be
recognized as a target for developing new anti-epileptic
therapies.
CONCLUDING REMARKS
The intent of this review was to summarize the findings
describing novel roles of astrocytes in the brain. Astrocytes
can exocytotically release a variety of gliotransmitters under
physiological and pathological conditions. This gliotransmis-
sion in turn can modulate synaptic transmission and plasticity
and can also contribute to sleep behaviour. Although
astrocytes can play a role in various disease states of the
brain, as reviewed elsewhere (Verkhratsky and Parpura, 2010),
we solely focused on epilepsy in which astrocytic Ca
2+
homoeostasis and gliotransmission can contribute to the
aetiology of this disorder. Although these exciting findings
shed new light on the brain operation in health and disease,
featuring astrocytes as an integral component of brain’s
functions, they also raise many new issues that remain to be
addressed. For example, how various release mechanisms for
gliotransmitters operate under (patho)physiological condi-
tions need to be systemically investigated. For vesicular
gliotransmitter release alone, it would have to be determined
how various gliotransmitters, individually and/or in blend(s),
affect neurotransmission in different brain regions and
account for different behaviours. It is clear at this juncture
that such a colossal task would require the use of various
levels of analysis, from single cells to the complex network in
the living brain, and comprehensive utilization of a battery of
experimental approaches, including molecular genetics,
imaging, electrophysiology and behavioural testing.
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